Undertreatment of people with major depressive disorder in 21 countries
King's College London · World Health Organization · +31 more institutions
Indexed incrossrefpubmed
Abstract
Background
Major depressive disorder (MDD) is a leading cause of disability worldwide.
Aims
To examine the: (a) 12-month prevalence of DSM-IV MDD; (b) proportion aware that they have a problem needing treatment and who want care; (c) proportion of the latter receiving treatment; and (d) proportion of such treatment meeting minimal standards. METHOD: Representative community household surveys from 21 countries as part of the World Health Organization World Mental Health Surveys.
Citation impact
1,106
total citations
- FWCI
- 72.59
- Percentile
- 100%
- References
- 38
Citations per year
Authors
27Topics & keywords
Topics
Keywords
- Major depressive disorder
- Outreach
- Mental health
- Psychiatry
- Medicine
- Depression (economics)
- Economic growth
UN Sustainable Development Goals
- No poverty
No related works found for this paper.
Funding
- RWRobert Wood Johnson FoundationAwards: 044708, Grant 044708
- JDJohn D. and Catherine T. MacArthur FoundationAwards: R01 DA016558, R13-MH066849
- JWJohn W. Alden Trust
- BSBristol-Myers Squibb
- ELEli Lilly and Company
- PPfizer
- AAstraZeneca
- GGlaxoSmithKline
- SSanofi
- WHWorld Health Organization
- SLSouth London and Maudsley NHS Foundation Trust
- KCKing's College Hospital NHS Foundation Trust
- GOGovernment of the United Kingdom
- UCUniversidad CES
- NINational Institute for Health and Care ResearchAward: FP7/2007-2013
- KCKing's College London
- ECEuropean CommissionAwards: EAHC 20081308, 20081308, FP7/2007-2013, QLG5-1999-01042, 2004123, 2007-2013, FP7/2007, SANCO 2004123
- PHPublic Health Agency
- FDFundação de Amparo à Pesquisa do Estado de São PauloAwards: 03/00204-3, 03/00204-
- GDGeneralitat de CatalunyaAward: 01042
- BFBundesministerium für Gesundheit
- NINational Insurance Institute of Israel
- MDMinisterio de Salud de la Nación
- MOMinistry of Health, Labour and Welfare
- CNConselho Nacional de Desenvolvimento Científico e TecnológicoAwards: 307623/2013-0, 2013-0
- UDUniversidade de Lisboa
- MDMinisterio de Ciencia y TecnologíaAward: SAF 2000-158-CE
- FPFundación para la Formación e Investigación Sanitarias de la Región de Murcia
- SMServicio Murciano de Salud
- RPRegione PiemonteAward: 00/0028
- FMFakultet Medicinskih Nauka, Univerziteta U Kragujevcu
- SServier
- HLH. Lundbeck A/S
- FCFundação ChampalimaudAward: R01 MH070884
- MDMinisterio de Salud
- SASubstance Abuse and Mental Health Services Administration
- PFPfizer FoundationAwards: R01-MH069864, R01 DA016558, R13-MH066849, R03-TW006481
- PAPan American Health Organization
- EAExecutive Agency for Health and Consumers
- FPFundação para a Ciência e a Tecnologia
- IDInstituto de Salud Carlos IIIAwards: CB06/02/0046, CIBER CB06/02/0046, RETICS RD06/0011 REM-TAP, RETICS RD06/0011, RD06/0011, FIS 00/0028, CIBER CB06/02/0046
- CDConsejería de Sanidad y Política Social, Comunidad Autónoma de la Región de Murcia
- DDDepartament de Salut, Generalitat de Catalunya
- NINational Institute of Mental HealthAwards: U01-MH60220, NIMH; R01 MH070884, R01-MH069864, MH60220, MH070884, R01 MH070884, R13-MH066849
- NINational Institute on Drug AbuseAward: R01 DA016558
- FIFogarty International CenterAwards: R03-TW006481, R03 TW006481-01, FIRCA R03-TW006481
- CCilag